Historical index on Taiwan OTC Exchange :
B
"Should I invest in Synmosa Biopharma stock?"
"Should I trade "4114" stock today?"
According to our live Forecast System,
Synmosa Biopharma Corporation stock is
a bad
long-term (1-year) investment*.
"4114" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.
Q&A about "4114" projections.
See Our Other Forecasts
At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like
Synmosa Biopharma Corporation (4114).
If you are looking for stocks with good return, Synmosa Biopharma Corporation
can be a bad, high-risk 1-year investment option.
Synmosa Biopharma Corporation quote is equal to
34.60 at 2026-02-17, but your current investment may be devalued in the future.
Based on our forecasts, a long-term decrease is expected,
the "4114" stock price prognosis for 2031-02-17
is 4.956. With a 5-year investment, the revenue is expected to be around
-85.68%.
Your current $100 investment may be down to $14.32 in 2031.
Synmosa Biopharma Corporation Forecast,
Short-Term 4114 Stock Price Prediction for Next Days and Weeks
Synmosa Biopharma Corporation Forecast,
Long-Term Price Predictions for Next Months and Year: 2026, 2027, 2028, 2029, 2030
4114 Target Price
Synmosa Biopharma Corporation price target in 14 days:
34.85* upside and
33.81* downside.
(Highest and lowest possible predicted price in a 14 day period)
Synmosa Biopharma Corporation forecast* for tomorrow, and next weeks based on the last 30 days
Question Box: How will Synmosa Biopharma Corporation stock price increase? Will 4114 price go up? Will Synmosa Biopharma Corporation stock price fall? Will 4114 price drop? Will 4114 stock price rise? Is Synmosa Biopharma Corporation price going up? Is Synmosa Biopharma Corporation a profitable investment? Is 4114 stock price going to drop? When will 4114 price fall? When will 4114 stock price go down? When will Synmosa Biopharma Corporation price drop?
* Our share forecasts and predictions are made by Machine Learning & Ai, and shouldn't been used for financial decisions. We can't guarantee any profit.